Genopathy
Gene-Disorder Association · Article
Gene
F13A1
Coagulation Factor XIII A Chain
Disorder
Myocardial Infarction
First reported 1950
Supporting publications 1
Key publication · disorder [Contribution to the problem of the allergic etiology of angina pectoris and myocardial infarct].Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin · 1950
Manually curatedApproved treatment annotated
Association Review

In brief

The association between F13A1 (Coagulation Factor XIII A Chain) and Myocardial Infarction is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording a known molecular basis, pathogenic variants, and a susceptibility locus.

Sources 3
Clinical variants 4
Symptoms 3
Compounds 2
Trials 98of 1,560 via F13A1 compounds
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

3 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
F13A1

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Myocardial Infarction

The disorder

11 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

4 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

1,560 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

8 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access